TGI
TNGX icon

TRV GP IV’s Tango Therapeutics TNGX Stock Holding History

TRV GP IV’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$120M Hold
6,374,574
– – 47.37% 2
2026
Q1 		$133M Sell
6,374,574
-1,500,000
-19% -$20.9M 49.96% 2
2025
Q4 		$69.8M Sell
7,874,574
-5,989,401
-43% -$51.6M 27.35% 2
2025
Q3 		$116M Sell
13,863,975
-2,995,100
-18% -$20.3M 42.51% 2
2025
Q2 		$86.3M Hold
16,859,075
– – 52.85% 1
2025
Q1 		$23.1M Hold
16,859,075
– – 24.88% 2
2024
Q4 		$52.1M Hold
16,859,075
– – 64.97% 1
2024
Q3 		$130M Sell
16,859,075
-2,342,400
-12% -$22.4M 80.09% 1
2024
Q2 		$165M Hold
19,201,475
– – 81.48% 1
2024
Q1 		$152M Sell
19,201,475
-162,500
-0.8% -$1.74M 73.88% 1
2023
Q4 		$192M Hold
19,363,975
– – 77.88% 1
2023
Q3 		$218M Hold
19,363,975
– – 82.15% 1
2023
Q2 		$64.3M Hold
19,363,975
– – 58.09% 1
2023
Q1 		$76.5M Hold
19,363,975
– – 54.67% 1
2022
Q4 		$140M Hold
19,363,975
– – 59.7% 1
2022
Q3 		$70.1M Hold
19,363,975
– – 40.96% 1
2022
Q2 		$87.7M Hold
19,363,975
– – 57.68% 1
2022
Q1 		$147M Hold
19,363,975
– – 53.77% 1
2021
Q4 		$212M Hold
19,363,975
– – 60.92% 1
2021
Q3 		$250M Buy
+19,363,975
New +$232M 56.81% 1

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

TRV GP IV's TNGX Position: Q2 2026 in Review

TRV GP IV held its Tango Therapeutics (TNGX) position steady in Q2 2026 at 6,374,574 shares worth $120M. The position accounts for 47.37% of the portfolio, ranked #2.

TRV GP IV first reported a position in TNGX in Q3 2021 and has held it in 20 quarters since. The position peaked at $250M in Q3 2021. 249 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • TRV GP IV held 6,374,574 shares of Tango Therapeutics worth $120M as of Q2 2026.
  • TRV GP IV left its Tango Therapeutics share count unchanged in Q2 2026.
  • Tango Therapeutics made up 47.37% of TRV GP IV's portfolio in Q2 2026, its #2 holding.
  • TRV GP IV first reported a position in Tango Therapeutics in Q3 2021 and has held it in 20 quarters since.
  • TRV GP IV's Tango Therapeutics position peaked at $250M in Q3 2021.
  • 249 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on TRV GP IV's 13F filing for Q2 2026, filed 10 Aug 2026.